West Pharmaceutical Services is a manufacturer in the design and production of integrated containment and delivery systems for injectable drugs and healthcare products. Co.'s business operations are organized into two reportable segments: Proprietary Products, which provides proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, mainly to biologic, generic and pharmaceutical drug customers; and Contract-Manufactured Products, which serves as an integrated business, focused on the design, manufacture, and automated assembly of devices, mainly for pharmaceutical, diagnostic, and medical device customers. The WST stock yearly return is shown above.
The yearly return on the WST stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the WST annual return calculation with any dividends reinvested as applicable (on ex-dates).
|